Oder Investment Management’s Tema Oncology ETF CANC Stock Holding History
Bought
Maintained
Sold
Other funds holding CANC
Oder Investment Management's CANC Position: Q3 2026 in Review
Oder Investment Management increased its Tema Oncology ETF (CANC) stake by 9.4% in Q3 2026, buying an estimated $49.4K and bringing the position to 13,572 shares worth $570K. The position accounts for 0.37% of the portfolio, ranked #69.
Oder Investment Management first reported a position in CANC in Q2 2026 and has held it in 2 quarters since. 17 funds tracked by Wall St. Rank hold CANC as of Q3 2026.
- Oder Investment Management held 13,572 shares of Tema Oncology ETF worth $570K as of Q3 2026.
- Oder Investment Management bought 1,169 Tema Oncology ETF shares in Q3 2026, an estimated $49.4K.
- Tema Oncology ETF made up 0.37% of Oder Investment Management's portfolio in Q3 2026, its #69 holding.
- Oder Investment Management first reported a position in Tema Oncology ETF in Q2 2026 and has held it in 2 quarters since.
- 17 funds tracked by Wall St. Rank held Tema Oncology ETF as of Q3 2026.
Based on Oder Investment Management's 13F filing for Q3 2026, filed 9 Nov 2026.